The median nadir Hb during hospitalization was 5.6 (IQR 4.5, 7.0) g/dL, which increased after treatment for anemia to 7.3 (IQR 6.2, 8.4) g/dL upon discharge (Fig 1). The gene discussed is GSTM1; the disease is anemia.